Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Acta Biomater. 2012 Mar 8;8(6):2223–2232. doi: 10.1016/j.actbio.2012.03.003

Table I.

Formulation of Poloxamine and DTT Solutions

Tetronic® / Tetronic® ACR Solution DTT/Buffer Solution
T1107/T904 composition T1107 (mg) T904 (mg) PBS (μl) DTT (mg) PBS (μl)
100/0 30 0 60 0.61 10
75/25 22.5 7.5 0.79
50/50 15 15 0.97
0/100 0 30 1.35

PEG control formulation: 30 mg 4-arm 10 kDa PEG in 60 μl PBS and 0.93 mg DTT in 10 μl PBS. Buffer alone without added DTT was used for reverse thermal gelation analysis.